AJCC |
American Joint Committee on Cancer |
BAP1 |
BRCA1 associated protein 1 |
BCL2 |
B-cell lymphoma 2 |
BCL2A1 |
BCL2 related protein A1 |
BCL2L1 |
BCL2 like 1 |
BCLxL |
B-cell lymphoma-extra large |
BPS |
Branchpoint sequence |
BRD9 |
Bromodomain containing 9 |
BUD31 |
BUD31 homolog |
CLL |
Chronic Lymphocytic Leukemia |
CSV |
Chromosomal structural variants |
CYSLTR2 |
Cysteinyl Leukotriene Receptor 2 |
DDX46 |
DEAD-Box Helicase 46 |
DNA-PK |
DNA-dependent protein kinase |
EIF1AX |
Eukaryotic Translation Initiation Factor 1A X-Linked |
EOE |
Extraocular tumor extension |
ESE |
Exonic splicing enhancer |
FAG |
Fluorescein Angiography |
GNAQ |
G protein Subunit Alpha Q |
GNA11 |
G protein Subunit Alpha 11 |
GPCR |
G protein-coupled receptors |
HEAT |
Huntington, Elongation factor 3, protein phosphatase 2A, targets of rapamycin 1 |
HR |
Homology recombination |
K |
Lysine |
M3G8q |
Monosomy 3, gain of 8q |
MCL1 |
MCL1 apoptosis regulator |
MDS |
Myelodysplastic syndromes |
MUT |
Mutated |
MYC |
MYC proto-oncogene, BHLH transcription factor |
ncBAF |
Non-canonical BAF |
NHEJ |
Non-homologous end joining |
NMD |
Nonsense mediated decay |
PLCB4 |
Phospholipase C Beta 4 |
PRMT5 |
Protein Arginine Methyltransferase 5 |
Py |
Polypyrimidine |
R |
Arginine |
RARS |
Refractory anemia with ring sideroblasts |
SF3B1 |
Splicing Factor 3b Subunit 1 |
SRSF2 |
Serine- and arginine-rich splicing factor 2 |
snRNP |
Small nuclear ribonucleoprotein particles |
TERT |
Telomerase reverse transcriptase |
TNM |
Tumor-node-metastasis |
U2AF |
U2 small nuclear RNA auxiliary factor |
U2AF2 |
U2 small nuclear RNA auxiliary factor 2 |
UM |
Uveal melanoma |
US |
Ultrasonography |
WT |
Wild type |